Project Grant HT9425261E170
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
- Federal Grant Award Summary The University of California, Davis received a $1.73 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. This award supports research and development activities focused on novel therapeutics targeting Bromodomain and Extra-Terminal (BET) protein-mediated oncogenesis in lethal prostate cancer. The research will be conducted at UC...
- Federal Project Grant Award Summary The University of California, Davis received a $481,056 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 30, 2025 through September 29, 2027. The award supports research investigating ARHGEF2 in promoting neural lineage plasticity and treatment resistance in advanced prostate cancer. This research aligns with the program's focus on transforming healthcare for...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California Irvine a $747,092 Project Grant effective September 1, 2026, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "Immune Checkpoint Inhibition-Related Cognitive Impairments: Mechanisms and Mitigation," supports basic and applied biomedical research investigating cognitive side effects associated with immunotherapy...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California Irvine a $1.35 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate immune checkpoint inhibition-related cognitive impairments, with a focus on elucidating mechanisms and developing mitigation strategies. The three-year research initiative, effective September 1, 2026 through August 31, 2029, will be conducted at UCI's Irvine, California...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco a $1.4 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through July 31, 2029. The award supports investigator-initiated research into the metabolic mechanisms of resistance to mutant isocitrate dehydrogenase (IDH) inhibition in gliomas. This three-year research initiative will be conducted at...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded University of California, Davis $2.2M under the Military Medical Research and Development program (CFDA 12.420) to develop point-of-care scalable long-acting nanoparticle anesthetic tilapia dressing technology for burn wound and pain management. The project, initiated July 1, 2025, and concluding June 30, 2028, represents a three-year research initiative funded through the DHA's congressionally directed medical...
- The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
- Federal Grant Award Summary The Defense Health Agency awarded a $559,976 Project Grant to the University of California Irvine, effective September 1, 2026, through August 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The project, "Targeting Mechanosensing PIEZO1 Channels of CD8 T Cells to Improve Melanoma Tumor Immunity," supports basic and applied biomedical research addressing Service Member health priorities. The research focuses on...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $1,197,813 Project Grant to the University of California, San Diego on August 15, 2025, under the Military Medical Research and Development program (CFDA 12.420) for mechanism dissection and model development of human PD1 (Programmed Death receptor 1) in melanoma. The three-year award, with a completion date of August 14, 2028, supports basic and applied biomedical research investigating immunotherapeutic mechanisms relevant...